Home Everest Medicines and Mabworks Enter into Commercialization License Agreement for Beijieixin® to Deepen Asia-Pacific Innovative Drug Market Presence

Everest Medicines and Mabworks Enter into Commercialization License Agreement for Beijieixin® to Deepen Asia-Pacific Innovative Drug Market Presence

Jun 04, 2026 17:17 CST Updated Jun 05, 09:58
Everest Medicines

Developer of Innovative Therapies